FDA Inspection 1015411 — Charles River Laboratories, Inc.

Charles River Laboratories, Inc. — FEI 1000086712

The FDA completed an inspection of Charles River Laboratories, Inc. on June 21, 2017 in Wilmington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wilmington, MA (United States)

Citations

IDCFRDescription
108621 CFR 211.22(b)Adequate lab facilities not available
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
181021 CFR 211.160(a)Lab controls established, including changes
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation